1. Home
  2. XLO vs MNY Comparison

XLO vs MNY Comparison

Compare XLO & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • MNY
  • Stock Information
  • Founded
  • XLO 2016
  • MNY 2014
  • Country
  • XLO United States
  • MNY Singapore
  • Employees
  • XLO N/A
  • MNY N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • XLO Health Care
  • MNY
  • Exchange
  • XLO Nasdaq
  • MNY Nasdaq
  • Market Cap
  • XLO 42.1M
  • MNY 47.1M
  • IPO Year
  • XLO 2021
  • MNY N/A
  • Fundamental
  • Price
  • XLO $1.11
  • MNY $1.10
  • Analyst Decision
  • XLO Buy
  • MNY
  • Analyst Count
  • XLO 1
  • MNY 0
  • Target Price
  • XLO $4.00
  • MNY N/A
  • AVG Volume (30 Days)
  • XLO 738.6K
  • MNY 155.3K
  • Earning Date
  • XLO 11-07-2024
  • MNY 12-10-2024
  • Dividend Yield
  • XLO N/A
  • MNY N/A
  • EPS Growth
  • XLO N/A
  • MNY N/A
  • EPS
  • XLO N/A
  • MNY N/A
  • Revenue
  • XLO $4,620,000.00
  • MNY $90,185,081.00
  • Revenue This Year
  • XLO N/A
  • MNY $26.64
  • Revenue Next Year
  • XLO $368.76
  • MNY $25.46
  • P/E Ratio
  • XLO N/A
  • MNY N/A
  • Revenue Growth
  • XLO N/A
  • MNY 24.60
  • 52 Week Low
  • XLO $0.50
  • MNY $0.85
  • 52 Week High
  • XLO $1.93
  • MNY $3.46
  • Technical
  • Relative Strength Index (RSI)
  • XLO 54.59
  • MNY 44.96
  • Support Level
  • XLO $0.84
  • MNY $1.02
  • Resistance Level
  • XLO $1.28
  • MNY $1.13
  • Average True Range (ATR)
  • XLO 0.13
  • MNY 0.07
  • MACD
  • XLO 0.01
  • MNY -0.01
  • Stochastic Oscillator
  • XLO 62.72
  • MNY 29.82

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.

Share on Social Networks: